Falls during hospitalisation · acutely hospitalised older medical patients
Summary of findings table ‐ Progressive resistance exercise… showed no clear difference in falls during hospitalisation compared with usual care with or without sham interventions (low certainty).
1 finding from 1 review
Global assessment of treatment success · acutely hospitalised older medical patients
1 finding from 1 review
Functional ability: new incidence of delirium during hospitalisation · acutely hospitalised medical patients
It is very uncertain whether summary of findings table ‐ Exercise interventions changes functional ability: new incidence of delirium during hospitalisation compared with usual care with or without sham interventions (very low certainty).
1 finding from 1 review
Quality of life at discharge from hospital · acutely hospitalised medical patients
1 finding from 1 review
Falls during hospitalisation · acutely hospitalised medical patients
Summary of findings table ‐ Exercise interventions showed no clear difference in falls during hospitalisation compared with usual care with or without sham interventions (moderate certainty).
1 finding from 1 review
Global assessment of treatment success · acutely hospitalised medical patients
1 finding from 1 review
Functional ability: independence with activities of daily living at discharge from hospital · acutely hospitalised older medical patients
1 finding from 1 review
Functional ability: functional mobility at discharge from hospital · acutely hospitalised older medical patients
1 finding from 1 review
Clinical remission · Induction of Remission in Medically Refractory Crohn's Disease
Summary of findings table ‐ Stem Cell showed no clear difference in clinical remission compared with placebo or Control (low certainty).
1 finding from 1 review
CDAI <150 at 24 weeks · Induction of Remission in Medically Refractory Crohn's Disease
It is very uncertain whether summary of findings table ‐ Stem Cell changes CDAI <150 at 24 weeks compared with placebo or Control (very low certainty).
1 finding from 1 review
Fistula Closure short‐term · Induction of Remission in Medically Refractory Crohn's Disease
Summary of findings table ‐ Stem Cell may leads to higher fistula Closure short‐term compared with placebo or Control (low certainty).
1 finding from 1 review
Fistula closure in long‐term · Induction of Remission in Medically Refractory Crohn's Disease
Summary of findings table ‐ Stem Cell may leads to higher fistula closure in long‐term compared with placebo or Control (low certainty).
1 finding from 1 review
Total adverse events · Induction of Remission in Medically Refractory Crohn's Disease
It is very uncertain whether summary of findings table ‐ Stem Cell changes total Adverse Events compared with placebo or Control (very low certainty).
1 finding from 1 review
Serious adverse events · Induction of Remission in Medically Refractory Crohn's Disease
Summary of findings table ‐ Stem Cell showed no clear difference in serious Adverse Events compared with placebo or Control (low certainty).
1 finding from 1 review
Withdrawals due to adverse events · Induction of Remission in Medically Refractory Crohn's Disease
It is very uncertain whether summary of findings table ‐ Stem Cell changes withdrawal due to adverse events compared with placebo or Control (very low certainty).
1 finding from 1 review
Pain score · women having medical abortion before 14 weeks' gestation
1 finding from 1 review
Pain score · women having medical abortion before 14 weeks' gestation
1 finding from 1 review
Nausea · women having medical abortion before 14 weeks' gestation
Summary of findings table ‐ Pregabalin 300 mg showed no clear difference in gastrointestinal side effects (nausea) compared with placebo (low certainty).
1 finding from 1 review
Vomiting · women having medical abortion before 14 weeks' gestation
Summary of findings table ‐ Pregabalin 300 mg showed no clear difference in gastrointestinal side effects (vomiting) compared with placebo (low certainty).
1 finding from 1 review
Diarrhoea · women having medical abortion before 14 weeks' gestation
Summary of findings table ‐ Pregabalin 300 mg showed no clear difference in gastrointestinal side effects (diarrhoea) compared with placebo (low certainty).
1 finding from 1 review